Article Text

PDF
Retinopathy in an obesity WHO III cohort: prevalence and risk factors
  1. Juri Mattern1,
  2. Alexander Lammert1,
  3. Mirko Otto2,
  4. Hans-Peter Hammes1
  1. 15th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany
  2. 2Surgical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany
  1. Correspondence to Professor Hans-Peter Hammes, 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, Mannheim 68167, Germany; hp.hammes{at}umm.de

Abstract

Objective To assess retinopathy and its risk factors in an obesity WHO III cohort.

Methods In the Mannheim Obesity Study, 277 subjects with obesity WHO III aged 18–64 years were examined in a cross-sectional approach. Screening for retinopathy was performed using 3-field retinal photography. Endothelial function was assessed using arteriole-to-venule ratio and flicker light analysis. Subjects with and without retinopathy were analysed for anthropometry, metabolic, vascular and renal parameters.

Results Retinopathy was found in 18 of the 277 subjects (6.5%). Prevalence of retinopathy was 16.7% in subjects with and 3.4% in subjects without diabetes mellitus. Between subjects with and without retinopathy there were significant differences in diabetes prevalence (61.1% vs 21.7%, p<0.001), systolic blood pressure (145.56 vs 131.73 mm Hg, p=0.005), intima-media thickness (0.7 vs 0.59 mm, p=0.034), dilatation of retinal veins in response to flicker light (2.24% vs 4.28%, p=0.004) and creatinine (0.92 vs 0.83 mg/dL, p=0.011). Stepwise logistic regression analysis revealed that the presence of diabetes mellitus led to an 8.3-fold increased risk for retinopathy (OR 8.3, p=0.049, 95% CI 1.01 to 67.49), whereas risk for retinopathy decreased by nearly 50% (OR 0.54, p=0.032, 95% CI 0.30 to 0.95) with each percentage increase in venous dilatation in response to flicker light.

Conclusions Retinopathy prevalence in our obesity WHO III cohort is low. Presence of diabetes mellitus is the most important risk factor for retinopathy. Preserved venular function indicates protection from retinopathy.

Trial registration number NCT00770276, Results.

Statistics from Altmetric.com

Footnotes

  • Contributors JM investigated patients, searched data, drafted and revised the manuscript. AL investigated patients, searched data, revised manuscript. MO investigated patients, searched data, revised manuscript. H-PH designed the study, investigated patients, drafted and revised the manuscript.

  • Competing interests None declared.

  • Ethics approval Ethics Committee of the Universitätsmedizin Mannheim.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.